ARK Investment Management LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)

Filing Manager
ARK Investment Management LLC
Reporting Manager
ARK Investment Management LLC
Security
Recursion Pharmaceuticals, Inc. Class A Common Stock
Symbol
RXRX
Shares outstanding
514,715,255 shares
Disclosed Ownership
37,316,856 shares
Ownership
7.2%
Form type
SCHEDULE 13G/A
Filing time
03 Feb 2026, 11:38:13 UTC
Date of event
31 Dec 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ARK Investment Management LLC 7.2% 37,316,856 35,278,842 592,161 /s/ Kellen Carter Kellen Carter, Chief Compliance Officer
Catherine D. Wood 7.2% 37,316,856 0 35,871,003 /s/ Catherine D. Wood Catherine D. Wood, Chief Executive Officer, Chief Investment Officer